Nitric oxide infused surgical tissue repair technologies

Patent metadata

Field	Value
Publication number	US-2021338461-A1
Application number	US-202117224942-A
Country	US
Kind code	A1
Filing date	Apr 7, 2021
Priority date	Apr 30, 2020
Publication date	Nov 4, 2021
Grant date	—

Abstract

Surgical tissue repair technologies incorporating nitric oxide releasing materials which release nitric oxide into the surrounding tissue. The surgical tissue repair technologies include tissue repair devices, such as surgical meshes, vascular stents, surgical grafts, irrigation solutions, and other internal surgical tissue repair materials. The nitric oxide releasing compound may be a S-nitrosothiol compound, such as s-nitroso-n-acetyl penicillamine (SNAP), s-nitrosoglutathione (GSNO), and mixtures thereof. The tissue repair devices may further include a catalyst to facilitate release of nitric oxide. The devices may include a substrate coated with a coating incorporating the same or different nitric oxide releasing compound. The devices may include a substrate impregnated with the nitric oxide releasing compound and coated with a polymer-based coating incorporating the same or different nitric oxide releasing compound. The polymer-based coating may include diazeniumdiolate groups (NONOate groups). The polymer-based coating may include a polyethyleneimine cellulose NONOate polymer.

First claim

1 . A surgical tissue repair device configured to be implanted during tissue repair surgery and which releases nitric oxide into the surrounding tissue, wherein the device comprises a substrate incorporating a nitric oxide releasing compound.

2 . The surgical tissue repair device of claim 1 , wherein the nitric oxide releasing compound is a S-nitrosothiol compound.

3 . The surgical tissue repair device of claim 1 , wherein the nitric oxide releasing compound is selected from s-nitroso-n-acetyl penicillamine (SNAP), s-nitrosoglutathione (GSNO), and mixtures thereof.

4 . The surgical tissue repair device of claim 1 , wherein the nitric oxide releasing compound reacts in the presence of a physiological fluid to release nitric oxide into the surrounding tissue.

5 . The surgical tissue repair device of claim 4 , wherein the physiological fluid is selected from interstitial fluid and blood.

6 . The surgical tissue repair device of claim 1 , wherein the substrate further incorporates a catalyst to facilitate release of nitric oxide.

7 . The surgical tissue repair device of claim 6 , wherein the catalyst is selected from copper, iron, zinc, selenium, and silver.

8 . The surgical tissue repair device of claim 1 , wherein the substrate comprises a surgical mesh.

9 . The surgical tissue repair device of claim 1 , wherein the substrate comprises a surgical graft.

10 . The surgical tissue repair device of claim 1 , wherein the substrate comprises a vascular stent.

11 . The surgical tissue repair device of claim 1 , wherein the substrate is a polymeric material impregnated with the nitric oxide releasing compound.

12 . The surgical tissue repair device of claim 1 , wherein the substrate is coated with a polymer-based coating incorporating the same or different nitric oxide releasing compound.

13 . The surgical tissue repair device of claim 1 , wherein the substrate is impregnated with the nitric oxide releasing compound and coated with a polymer-based coating incorporating the same or different nitric oxide releasing compound.

14 . The surgical tissue repair device of claim 12 , wherein the polymer-based coating comprises diazeniumdiolate groups (NONOate groups).

15 . The surgical tissue repair device of claim 12 , wherein the polymer-based coating comprises a polyethyleneimine cellulose NONOate polymer.

16 . The surgical tissue repair device of claim 13 , wherein the polymer-based coating comprises diazeniumdiolate groups (NONOate groups).

17 . The surgical tissue repair device of claim 13 , wherein the polymer-based coating comprises a polyethyleneimine cellulose NONOate polymer.

18 . A surgical tissue repair device configured to be implanted during tissue repair surgery which releases nitric oxide into the surrounding tissue, wherein the device comprises a polymeric substrate incorporating a S-nitrosothiol compound selected from s-nitroso-n-acetyl penicillamine (SNAP), s-nitrosoglutathione (GSNO), and mixtures thereof, which releases the nitric oxide, wherein the tissue repair device is selected from a surgical mesh, a surgical graft, and a vascular stent.

19 . The surgical tissue repair device of claim 18 , wherein the substrate further incorporates a catalyst to facilitate release of nitric oxide.

20 . The surgical tissue repair device of claim 19 , wherein the catalyst is selected from copper, iron, zinc, selenium, and silver.

Assignees

• Becton Dickinson Co

Inventors

• Laine Brendan
• Ofek Gidon

Classifications

• A61F2/82

  Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title

• A61F2250/0067

  Means for introducing or releasing pharmaceutical products into the body · CPC title

• A61F2/0063

  Implantable repair or support meshes, e.g. hernia meshes · CPC title

• A61F2/0045

  Support slings · CPC title

• C09D101/08

  Cellulose derivatives · CPC title